 | • レポートコード：MRC2Q12-17102 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、セリアック病検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 セリアック病検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 セリアック病検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 セリアック病検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのセリアック病検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のセリアック病検査の売上および2028年までの予測に焦点を当てています。 セリアック病検査のグローバル主要企業には、PRIMA Lab SA、Glutenostics、NanoRepro、Thermo Fisher Scientific、Targeted Genomics、YorkTest、Biohit Oyj、Labsystems Diagnostics Oy、Biomerica、Smartbloodなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 セリアック病検査市場は、タイプとアプリケーションによって区分されます。世界のセリアック病検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 血清学的検査、遺伝子検査、腸生検、その他 【アプリケーション別セグメント】 病院、診断研究所、ホームケア、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - セリアック病検査製品概要 - タイプ別市場（血清学的検査、遺伝子検査、腸生検、その他） - アプリケーション別市場（病院、診断研究所、ホームケア、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のセリアック病検査販売量予測2017-2028 - 世界のセリアック病検査売上予測2017-2028 - セリアック病検査の地域別販売量 - セリアック病検査の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別セリアック病検査販売量 - 主要メーカー別セリアック病検査売上 - 主要メーカー別セリアック病検査価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（血清学的検査、遺伝子検査、腸生検、その他） - セリアック病検査のタイプ別販売量 - セリアック病検査のタイプ別売上 - セリアック病検査のタイプ別価格 ・アプリケーション別市場規模（病院、診断研究所、ホームケア、その他） - セリアック病検査のアプリケーション別販売量 - セリアック病検査のアプリケーション別売上 - セリアック病検査のアプリケーション別価格 ・北米市場 - 北米のセリアック病検査市場規模（タイプ別、アプリケーション別） - 主要国別のセリアック病検査市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのセリアック病検査市場規模（タイプ別、アプリケーション別） - 主要国別のセリアック病検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のセリアック病検査市場規模（タイプ別、アプリケーション別） - 主要国別のセリアック病検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のセリアック病検査市場規模（タイプ別、アプリケーション別） - 主要国別のセリアック病検査市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのセリアック病検査市場規模（タイプ別、アプリケーション別） - 主要国別のセリアック病検査市場規模（トルコ、サウジアラビア） ・企業情報 PRIMA Lab SA、Glutenostics、NanoRepro、Thermo Fisher Scientific、Targeted Genomics、YorkTest、Biohit Oyj、Labsystems Diagnostics Oy、Biomerica、Smartblood ・産業チェーン及び販売チャネル分析 - セリアック病検査の産業チェーン分析 - セリアック病検査の原材料 - セリアック病検査の生産プロセス - セリアック病検査の販売及びマーケティング - セリアック病検査の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - セリアック病検査の産業動向 - セリアック病検査のマーケットドライバー - セリアック病検査の課題 - セリアック病検査の阻害要因 ・主な調査結果 |
Celiac disease is a digestive disorder that causes the body to have difficulty absorbing nutrients like fat, calcium, iron, and folate. It is an autoimmune disease in which gluten-containing foods cause damage to the small intestine lining.Celiac disease is diagnosed using a combination of serologic tests, small bowel biopsy, and a gluten-free diet response. Several serologic antibody tests can be used as initial tests. Antigliadin antibodies are no longer recommended for initial testing due to their low sensitivity and specificity.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Celiac Disease Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Celiac Disease Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Celiac Disease Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Celiac Disease Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Celiac Disease Testing include PRIMA Lab SA, Glutenostics, NanoRepro, Thermo Fisher Scientific, Targeted Genomics, YorkTest, Biohit Oyj, Labsystems Diagnostics Oy and Biomerica, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Celiac Disease Testing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Celiac Disease Testing market. Further, it explains the major drivers and regional dynamics of the global Celiac Disease Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
PRIMA Lab SA
Glutenostics
NanoRepro
Thermo Fisher Scientific
Targeted Genomics
YorkTest
Biohit Oyj
Labsystems Diagnostics Oy
Biomerica
Smartblood
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Celiac Disease Testing Segment by Type
Serologic Tests
Genetic Tests
Intestinal Biopsies
Others
Celiac Disease Testing Segment by Application
Hospitals
Diagnostic Laboratories
Home Care
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Celiac Disease Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Celiac Disease Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Celiac Disease Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Celiac Disease Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Celiac Disease Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Celiac Disease Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Celiac Disease Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including PRIMA Lab SA, Glutenostics, NanoRepro, Thermo Fisher Scientific, Targeted Genomics, YorkTest, Biohit Oyj, Labsystems Diagnostics Oy and Biomerica, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Celiac Disease Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Celiac Disease Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Celiac Disease Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Celiac Disease Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Serologic Tests
1.2.3 Genetic Tests
1.2.4 Intestinal Biopsies
1.2.5 Others
1.3 Market by Application
1.3.1 Global Celiac Disease Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Home Care
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Celiac Disease Testing Market Perspective (2017-2028)
2.2 Celiac Disease Testing Growth Trends by Region
2.2.1 Celiac Disease Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Celiac Disease Testing Historic Market Size by Region (2017-2022)
2.2.3 Celiac Disease Testing Forecasted Market Size by Region (2023-2028)
2.3 Celiac Disease Testing Market Dynamics
2.3.1 Celiac Disease Testing Industry Trends
2.3.2 Celiac Disease Testing Market Drivers
2.3.3 Celiac Disease Testing Market Challenges
2.3.4 Celiac Disease Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Celiac Disease Testing Players by Revenue
3.1.1 Global Top Celiac Disease Testing Players by Revenue (2017-2022)
3.1.2 Global Celiac Disease Testing Revenue Market Share by Players (2017-2022)
3.2 Global Celiac Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Celiac Disease Testing Revenue
3.4 Global Celiac Disease Testing Market Concentration Ratio
3.4.1 Global Celiac Disease Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Testing Revenue in 2021
3.5 Celiac Disease Testing Key Players Head office and Area Served
3.6 Key Players Celiac Disease Testing Product Solution and Service
3.7 Date of Enter into Celiac Disease Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Testing Breakdown Data by Type
4.1 Global Celiac Disease Testing Historic Market Size by Type (2017-2022)
4.2 Global Celiac Disease Testing Forecasted Market Size by Type (2023-2028)
5 Celiac Disease Testing Breakdown Data by Application
5.1 Global Celiac Disease Testing Historic Market Size by Application (2017-2022)
5.2 Global Celiac Disease Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Celiac Disease Testing Market Size (2017-2028)
6.2 North America Celiac Disease Testing Market Size by Type
6.2.1 North America Celiac Disease Testing Market Size by Type (2017-2022)
6.2.2 North America Celiac Disease Testing Market Size by Type (2023-2028)
6.2.3 North America Celiac Disease Testing Market Share by Type (2017-2028)
6.3 North America Celiac Disease Testing Market Size by Application
6.3.1 North America Celiac Disease Testing Market Size by Application (2017-2022)
6.3.2 North America Celiac Disease Testing Market Size by Application (2023-2028)
6.3.3 North America Celiac Disease Testing Market Share by Application (2017-2028)
6.4 North America Celiac Disease Testing Market Size by Country
6.4.1 North America Celiac Disease Testing Market Size by Country (2017-2022)
6.4.2 North America Celiac Disease Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Celiac Disease Testing Market Size (2017-2028)
7.2 Europe Celiac Disease Testing Market Size by Type
7.2.1 Europe Celiac Disease Testing Market Size by Type (2017-2022)
7.2.2 Europe Celiac Disease Testing Market Size by Type (2023-2028)
7.2.3 Europe Celiac Disease Testing Market Share by Type (2017-2028)
7.3 Europe Celiac Disease Testing Market Size by Application
7.3.1 Europe Celiac Disease Testing Market Size by Application (2017-2022)
7.3.2 Europe Celiac Disease Testing Market Size by Application (2023-2028)
7.3.3 Europe Celiac Disease Testing Market Share by Application (2017-2028)
7.4 Europe Celiac Disease Testing Market Size by Country
7.4.1 Europe Celiac Disease Testing Market Size by Country (2017-2022)
7.4.2 Europe Celiac Disease Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Celiac Disease Testing Market Size (2017-2028)
8.2 Asia-Pacific Celiac Disease Testing Market Size by Type
8.2.1 Asia-Pacific Celiac Disease Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Celiac Disease Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Celiac Disease Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Celiac Disease Testing Market Size by Application
8.3.1 Asia-Pacific Celiac Disease Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Celiac Disease Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Celiac Disease Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Celiac Disease Testing Market Size by Region
8.4.1 Asia-Pacific Celiac Disease Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Celiac Disease Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Celiac Disease Testing Market Size (2017-2028)
9.2 Latin America Celiac Disease Testing Market Size by Type
9.2.1 Latin America Celiac Disease Testing Market Size by Type (2017-2022)
9.2.2 Latin America Celiac Disease Testing Market Size by Type (2023-2028)
9.2.3 Latin America Celiac Disease Testing Market Share by Type (2017-2028)
9.3 Latin America Celiac Disease Testing Market Size by Application
9.3.1 Latin America Celiac Disease Testing Market Size by Application (2017-2022)
9.3.2 Latin America Celiac Disease Testing Market Size by Application (2023-2028)
9.3.3 Latin America Celiac Disease Testing Market Share by Application (2017-2028)
9.4 Latin America Celiac Disease Testing Market Size by Country
9.4.1 Latin America Celiac Disease Testing Market Size by Country (2017-2022)
9.4.2 Latin America Celiac Disease Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Celiac Disease Testing Market Size (2017-2028)
10.2 Middle East & Africa Celiac Disease Testing Market Size by Type
10.2.1 Middle East & Africa Celiac Disease Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Celiac Disease Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Celiac Disease Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Celiac Disease Testing Market Size by Application
10.3.1 Middle East & Africa Celiac Disease Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Celiac Disease Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Celiac Disease Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Celiac Disease Testing Market Size by Country
10.4.1 Middle East & Africa Celiac Disease Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Celiac Disease Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 PRIMA Lab SA
11.1.1 PRIMA Lab SA Company Details
11.1.2 PRIMA Lab SA Business Overview
11.1.3 PRIMA Lab SA Celiac Disease Testing Introduction
11.1.4 PRIMA Lab SA Revenue in Celiac Disease Testing Business (2017-2022)
11.1.5 PRIMA Lab SA Recent Developments
11.2 Glutenostics
11.2.1 Glutenostics Company Details
11.2.2 Glutenostics Business Overview
11.2.3 Glutenostics Celiac Disease Testing Introduction
11.2.4 Glutenostics Revenue in Celiac Disease Testing Business (2017-2022)
11.2.5 Glutenostics Recent Developments
11.3 NanoRepro
11.3.1 NanoRepro Company Details
11.3.2 NanoRepro Business Overview
11.3.3 NanoRepro Celiac Disease Testing Introduction
11.3.4 NanoRepro Revenue in Celiac Disease Testing Business (2017-2022)
11.3.5 NanoRepro Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Celiac Disease Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Celiac Disease Testing Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Targeted Genomics
11.5.1 Targeted Genomics Company Details
11.5.2 Targeted Genomics Business Overview
11.5.3 Targeted Genomics Celiac Disease Testing Introduction
11.5.4 Targeted Genomics Revenue in Celiac Disease Testing Business (2017-2022)
11.5.5 Targeted Genomics Recent Developments
11.6 YorkTest
11.6.1 YorkTest Company Details
11.6.2 YorkTest Business Overview
11.6.3 YorkTest Celiac Disease Testing Introduction
11.6.4 YorkTest Revenue in Celiac Disease Testing Business (2017-2022)
11.6.5 YorkTest Recent Developments
11.7 Biohit Oyj
11.7.1 Biohit Oyj Company Details
11.7.2 Biohit Oyj Business Overview
11.7.3 Biohit Oyj Celiac Disease Testing Introduction
11.7.4 Biohit Oyj Revenue in Celiac Disease Testing Business (2017-2022)
11.7.5 Biohit Oyj Recent Developments
11.8 Labsystems Diagnostics Oy
11.8.1 Labsystems Diagnostics Oy Company Details
11.8.2 Labsystems Diagnostics Oy Business Overview
11.8.3 Labsystems Diagnostics Oy Celiac Disease Testing Introduction
11.8.4 Labsystems Diagnostics Oy Revenue in Celiac Disease Testing Business (2017-2022)
11.8.5 Labsystems Diagnostics Oy Recent Developments
11.9 Biomerica
11.9.1 Biomerica Company Details
11.9.2 Biomerica Business Overview
11.9.3 Biomerica Celiac Disease Testing Introduction
11.9.4 Biomerica Revenue in Celiac Disease Testing Business (2017-2022)
11.9.5 Biomerica Recent Developments
11.10 Smartblood
11.10.1 Smartblood Company Details
11.10.2 Smartblood Business Overview
11.10.3 Smartblood Celiac Disease Testing Introduction
11.10.4 Smartblood Revenue in Celiac Disease Testing Business (2017-2022)
11.10.5 Smartblood Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer